[HTML][HTML] Referral, diagnosis, and pharmacological management of peripheral artery disease: perspectives from Taiwan
JK Lee, IC Hsieh, CH Su, HL Huang, MH Lei… - Acta Cardiologica …, 2023 - ncbi.nlm.nih.gov
Peripheral artery disease (PAD) imposes a heavy burden of major adverse cardiovascular
events that are associated with considerable mortality and morbidity, and major adverse …
events that are associated with considerable mortality and morbidity, and major adverse …
Asia-Pacific consensus statement on the management of peripheral artery disease: a report from the Asian Pacific society of atherosclerosis and vascular disease Asia …
MTB Abola, J Golledge, T Miyata, SW Rha… - … of atherosclerosis and …, 2020 - jstage.jst.go.jp
Background: Peripheral artery disease (PAD) is the most underdiagnosed, underestimated
and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There …
and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There …
Medical management of peripheral artery disease
TA Holder, JA Gutierrez, AW Aday - Cardiology clinics, 2021 - cardiology.theclinics.com
Lower extremity peripheral artery disease (PAD) is a malignant form of atherosclerosis
associated with a heightened risk of cardiovascular morbidity and mortality. 1 Many patients …
associated with a heightened risk of cardiovascular morbidity and mortality. 1 Many patients …
Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease
BL Abramson, M Al-Omran, SS Anand… - Canadian Journal of …, 2022 - Elsevier
Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …
high risk of cardiovascular and limb symptoms and complications, which affects their quality …
The importance of early diagnosis and treatment in peripheral arterial disease: insights from the PARTNERS and REACH registries
D Mukherjee, K Eagle - Current vascular pharmacology, 2010 - ingentaconnect.com
Peripheral arterial disease (PAD) is a progressive disease most often due to atherosclerosis
and characterized by obstruction of arterial blood flow in the lower limbs. The defining …
and characterized by obstruction of arterial blood flow in the lower limbs. The defining …
Medical Therapy for Peripheral Artery Disease
ME Canonico, CN Hess, RK Rogers… - Current Cardiology …, 2024 - Springer
Comprehensive medical and non-medical management of PAD patients is crucial to
improving patient outcomes, mitigating symptoms, and reducing the risk of MACE and …
improving patient outcomes, mitigating symptoms, and reducing the risk of MACE and …
[HTML][HTML] The treatment gap in peripheral artery disease
WR Hiatt, RK Rogers - Journal of the American College of Cardiology, 2017 - jacc.org
Although peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis, the
heightened cardiovascular risk in these patients has been consistently under-recognized by …
heightened cardiovascular risk in these patients has been consistently under-recognized by …
PAD awareness, risk, and treatment: new resources for survival-the USA PARTNERS program
AT Hirsch, WR Hiatt… - Vascular …, 2001 - journals.sagepub.com
Peripheral arterial disease (PAD) is a very common manifestation of atherosclerosis and is
associated with a high risk of cardiovascular morbidity and mortality. Despite the magnitude …
associated with a high risk of cardiovascular morbidity and mortality. Despite the magnitude …
[图书][B] Peripheral Artery Disease
ER Mohler, MR Jaff - 2017 - books.google.com
A comprehensive, quick-reference guide to the diagnosis and management of peripheral
artery disease for non-specialists With an aging population subject to an increasing number …
artery disease for non-specialists With an aging population subject to an increasing number …
Medical management of peripheral arterial disease: bridging the “gap”?
CD Owens, MS Conte - Circulation, 2012 - Am Heart Assoc
Peripheral artery disease (PAD) is estimated to affect 27 million individuals in Europe and
North America, and its prevalence is increasing in concert with recent demographic and risk …
North America, and its prevalence is increasing in concert with recent demographic and risk …